探寻一家系短期3例胃癌的临床病理及其相关肿瘤特征

doi:10.6040/j.issn.1671-7554.0.2022.0476

摘要/Abstract

摘要： 目的总结家族聚集性胃癌(FGC)的临床特征,为其防治提供一定的参考价值。方法回顾性收集2016年12月至2022年1月收治的同一家系兄弟姐妹3人先后患胃癌的临床资料,分析其一般情况、临床特点、治疗及转归,并随访至2022年3月。结果胃癌在此家系中呈聚集性发病,其中男2例、女1例,发病时平均年龄47岁,3例患者具有共同的生活及饮食习惯,符合FGC的诊断,明确诊断后均接受手术及术后化疗,现1例患者已故,另外2例患者定期复查。结论 FGC的发病率较低,本文报道的短期内同一家系兄弟姐妹3人先后都患胃癌更为罕见,因此,家族中有超过2人患胃癌时,一定要注意预防FGC的发生。

关键词: 胃癌, 家族聚集性, 临床病理特征

Abstract: Objective To summarize the clinical features of familial clustered gastric cancer to provide reference for the prevention and treatment. Methods The clinical data of 3 brothers and sisters from the same family admitted during Dec. 2016 and Jan. 2022 due to gastric cancer were retrospectively collected. The general condition, clinical characteristics, treatment and outcomes were analyzed. All patients were followed up until March 2022. Results Gastric cancer was clustered in this family, including 2 males and 1 female, with an average age of 47 years at the time of onset. The 3 patients had common living and eating habits, which were in line with the diagnosis of familial clustered gastric cancer. After surgery and postoperative chemotherapy, 1 patient was deceased, and the other 2 were regularly followed up. Conclusion The incidence of familial clustered gastric cancer is relatively low. It is rare that all three siblings in the same family have gastric cancer in a short period of time. Therefore, when there are more than 2 people in the family suffering from gastric cancer, familial aggregation of gastric cancer must be alerted.

Key words: Gastric cancer, Familial aggregation, Clinicopathological features

中图分类号:

R735.2

穆彦熹,汪文杰,陈康,姚亚龙,李金洲,魏浩旗,刘海鹏,黄泽平,陈晓. 探寻一家系短期3例胃癌的临床病理及其相关肿瘤特征[J]. 山东大学学报 (医学版), 2022, 60(11): 96-101.

MU Yanxi, WANG Wenjie, CHEN Kang, YAO Yalong, LI Jinzhou, WEI Haoqi, LIU Haipeng, HUANG Zeping, CHEN Xiao. Exploring the clinicopathological features of three cases of gastric cancer in one pedigree during short-term[J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 96-101.

参考文献 25

[1]	Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer [J]. Int J Surg Pathol, 2010,18(3 Suppl): 33S-36S.
[2]	Oliveira C, Pinheiro H, Figueiredo J, et al. Familial gastric cancer: genetic susceptibility, pathology, and implications for management [J]. Lancet Oncol, 2015,16(2): e60-70. doi: 10.1016/S1470-2045(14)71016-2.
[3]	崔建新, 陈凛. 遗传性胃癌、家族聚集性胃癌诊疗进展[J]. 解放军医学院学报, 2013, 34(10): 1089-1091. CUI Jianxin, CHEN Lin. Advances in diagnosis and treatment of hereditary and familial gastric cancer [J]. Academic Journal of Chinese PLA Medical School, 2013, 34(10): 1089-1091.
[4]	Washington K. 7th edition of the AJCC cancer staging manual: stomach [J]. Ann Surg Oncol, 2010, 17(12): 3077-3079.
[5]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[6]	Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations [J]. N Engl J Med, 2001, 344(25): 1904-1909.
[7]	Worthley DL, Phillips KD, Wayte N, et al. Gastric adenocarcinoma and proximal polyposis of the stomach(GAPPS): a new autosomal dominant syndrome [J]. Gut, 2012, 61(5): 774-779.
[8]	Blair VR, McLeod M, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines [J]. Lancet Oncol, 2020, 21(8): e386-e397. doi: 10.1016/S1470-2045(20)30219-9.
[9]	陈慧敏, 房静远. 家族性胃癌的研究进展[J]. 中华消化杂志, 2009, 1: 67-70. CHEN Huimin, FANG Jingyuan. Research progress of familial gastric cancer [J]. Chinese Journal of Digestion, 2009, 1: 67-70.
[10]	Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer [J]. Br J Cancer, 2010,102(2): 237-242.
[11]	中国家族遗传性肿瘤临床诊疗专家共识(2021年版)(3)——家族遗传性胃癌[J]. 中国肿瘤临床, 2021, 48(24): 1248-1252. Expert consensus on clinical diagnosis and treatment of familial hereditary tumors in China(2021 edition)(3)— familial hereditary gastric cancer [J]. Chinese Journal of Clinical Oncology, 2021, 48(24): 1248-1252.
[12]	Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer [J]. Nature, 1998, 392(6674): 402-405.
[13]	Vitelli-Storelli F, Rubín-García M, Pelucchi C, et al. Family history and gastric cancer risk: a pooled investigation in the stomach cancer pooling(STOP)project consortium [J]. Cancers(Basel), 2021, 13(15): 3844.
[14]	Kharazmi E, Babaei M, Fallah M, et al. Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study [J]. Clin Epidemiol, 2018, 10: 1169-1179. doi: 10.2147/CLEP.S168152.
[15]	Choi YJ, Kim N. Gastric cancer and family history [J]. Korean J Intern Med, 2016, 31(6): 1042-1053.
[16]	Song M, Camargo MC, Weinstein SJ, et al. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population [J]. Gastric Cancer, 2018, 21(5): 729-737.
[17]	Bakir T, Can G, Erkul S, et al. Stomach cancer history in the siblings of patients with gastric carcinoma [J]. Eur J Cancer Prev, 2000, 9(6): 401-408.
[18]	Bakir T, Can G, Siviloglu C, et al. Gastric cancer and other organ cancer history in the parents of patients with gastric cancer [J]. Eur J Cancer Prev, 2003, 12(3): 183-189.
[19]	Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer [J]. Lancet, 2020, 396(10251): 635-648.
[20]	Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors [J]. J Surg Oncol, 2013, 107(3): 230-236.
[21]	Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies [J]. Int J Mol Sci, 2020, 21(11): 4012.
[22]	Moy KA, Fan Y, Wang R, et al. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China [J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(9): 2287-2297.
[23]	Duell EJ, Travier N, Lujan-Barroso L, et al. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition(EPIC)cohort [J]. Am J Clin Nutr, 2011, 94(5): 1266-1275.
[24]	Hooi J, Lai WY, Ng WK, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis [J]. Gastroenterology, 2017, 153(2): 420-429.
[25]	Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and helicobacter pylori treatment [J]. N Engl J Med, 2020, 382(5): 427-436.

相关文章 15

[1]	张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[2]	陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[3]	郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83.
[4]	郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47.
[5]	孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18.
[6]	樊荣,李彬彬,马晓丽,汪运山,郏雁飞. 胃癌中DEC2、HIF-2α的表达及临床意义[J]. 山东大学学报 (医学版), 2023, 61(7): 12-18.
[7]	穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41.
[8]	郭崇勇,赵朋,刘海盟,王强, 贾宗师,张建. 胸前丘疹为首发表现的胃癌1例[J]. 山东大学学报 (医学版), 2023, 61(4): 119-120.
[9]	王赞,徐晓涵,张瑜,曲业敏,王明义,陈艾. 幽门螺杆菌感染对胃癌细胞糖酵解的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 16-24.
[10]	付佳,王路路,胡帅,陈哲平,刘东义,李青松,卢国栋,张贺,赵鑫,冯昌. 不同入路腰方肌阻滞对胃癌根治患者术后恢复的影响[J]. 山东大学学报 (医学版), 2022, 60(8): 50-57.
[11]	包舒晴,杨明月,刘端瑞,汪运山,郏雁飞. NOX4在幽门螺旋杆菌诱导胃癌细胞ROS中的作用[J]. 山东大学学报 (医学版), 2022, 60(6): 19-25.
[12]	王景,谢艳,李培龙,杜鲁涛,王传新. GZMB基因cg16212145位点的异常甲基化芯片测定对胃癌早筛的价值[J]. 山东大学学报 (医学版), 2022, 60(6): 26-34.
[13]	高惠茹,杜甜甜,王允山,杜鲁涛,王传新. 基于单细胞转录组测序数据分析胃癌调节性T细胞特征[J]. 山东大学学报 (医学版), 2022, 60(5): 43-49.
[14]	褚晏,刘端瑞,朱文帅,樊荣,马晓丽,汪运山,郏雁飞. DNA甲基化转移酶在胃癌中的表达及其临床意义[J]. 山东大学学报 (医学版), 2021, 59(7): 1-9.
[15]	罗兵. EB病毒对胃癌表观遗传学的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 30-39.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed